Citation: U. Lonn et al., PROGNOSTIC-SIGNIFICANCE OF C-ERB-B2 AMPLIFICATION IN FINE-NEEDLE BIOPSIES OF BREAST-CANCER PATIENTS NOT OPERATED AT DIAGNOSIS, Breast cancer research and treatment, 39(2), 1996, pp. 213-220
Authors:
LONN U
LONN S
INGELMANSUNBERG H
NILSSON B
STENKVIST B
Citation: U. Lonn et al., C-ERB-B2 INT-2 AMPLIFICATION APPEARS FASTER IN BREAST-CANCER PATIENTSRECEIVING 2ND-LINE ENDOCRINE TREATMENT/, International journal of cancer, 69(4), 1996, pp. 273-277
Citation: U. Lonn et al., HIGHER FREQUENCY OF GENE AMPLIFICATION IN BREAST-CANCER PATIENTS WHO RECEIVED ADJUVANT CHEMOTHERAPY, Cancer, 77(1), 1996, pp. 107-112
Citation: At. Aas et al., REDUCED FORMATION OF HIGH-MOLECULAR-WEIGHT DNA IN MURINE GLIOMAS TREATED WITH NITROSOUREA AND CHLORPROMAZINE, Anticancer research, 14(3A), 1994, pp. 1133-1136
Authors:
LONN U
LONN S
NILSSON B
SILFVERSWARD C
STENKVIST B
Citation: U. Lonn et al., DEMONSTRATION OF GENE-AMPLIFICATION BY PCR IN ARCHIVAL PARAFFIN-EMBEDDED BREAST-CANCER TISSUE, Breast cancer research and treatment, 30(2), 1994, pp. 147-152
Citation: U. Lonn et al., BREAST-CANCER - PROGNOSTIC-SIGNIFICANCE OF C-ERB-B2 AND INT-2 AMPLIFICATION COMPARED WITH DNA-PLOIDY, S-PHASE FRACTION, AND CONVENTIONAL CLINICOPATHOLOGICAL FEATURES, Breast cancer research and treatment, 29(3), 1994, pp. 237-245
Citation: U. Lonn et al., INTRATUMORAL HETEROGENEITY FOR AMPLIFIED GENES IN HUMAN BREAST-CARCINOMA, International journal of cancer, 58(1), 1994, pp. 40-45
Citation: U. Lonn et al., APPEARANCE OF AMPLIFIED THYMIDYLATE SYNTHASE OR DIHYDROFOLATE-REDUCTASE GENES IN STAGE-IV BREAST-CANCER PATIENTS RECEIVING ENDOCRINE TREATMENT, International journal of cancer, 54(2), 1993, pp. 237-242
Authors:
LONN U
LONN S
NYLEN U
FRIBERG S
STENKVIST B
Citation: U. Lonn et al., GENE AMPLIFICATION DETECTED IN CARCINOMA-CELLS FROM HUMAN URINARY-BLADDER WASHINGS BY THE POLYMERASE CHAIN-REACTION METHOD, Cancer, 71(11), 1993, pp. 3605-3610